Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurent Deferred Tax LiabilityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Cash & Equivalents: 2009-2025

Historic Revenue - Interest and Investment Income for Amdocs (DOX) over the last 7 years, with Dec 2017 value amounting to $2.8 billion.

  • Amdocs' Cash & Equivalents fell 6.09% to $325.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $325.0 million, marking a year-over-year decrease of 6.09%. This contributed to the annual value of $346.1 million for FY2025, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Amdocs reported Cash & Equivalents of $325.0 million as of Q3 2025, which was down 6.09% from $346.1 million recorded in Q2 2025.
  • Amdocs' 5-year Cash & Equivalents high stood at $983.2 million for Q1 2021, and its period low was $325.0 million during Q3 2025.
  • In the last 3 years, Amdocs' Cash & Equivalents had a median value of $520.1 million in 2024 and averaged $464.6 million.
  • In the last 5 years, Amdocs' Revenue - Interest and Investment Income rose by 8.26% in 2014 and then fell by 27.87% in 2015.
  • Quarterly analysis of 5 years shows Amdocs' Revenue - Interest and Investment Income stood at $3.3 billion in 2013, then rose by 2.58% to $3.4 billion in 2014, then declined by 27.87% to $2.5 billion in 2015, then grew by 5.57% to $2.6 billion in 2016, then climbed by 7.17% to $2.8 billion in 2017.
  • Its last three reported values are $325.0 million in Q3 2025, $346.1 million for Q2 2025, and $346.1 million during Q1 2025.